Aptagen, LLC
* The secondary structure may not be accurate because of MFOLD limitations on chemistries other than RNA/DNA.
Human Colorectal Cancer WiDr Cell Line (HEW-K16) (ID# 7582)
Peptide
Human Colorectal Cancer (WiDr Cell Line)
Cells
N/A nM (reported value)
107 cells/mL in PBS and 1.0% BSA with 1.5x1011 phages/mL
RT°C
NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
NH2-HisGluTrpSerTyrLeuAlaProTyrProTrpPheLys-COOH
13
1878.16
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Rasmussen et al. "Tumor cell-targeting by phage-displayed peptides." Cancer Gene Therapy, 9(2002): 606-612
Have your aptamer oligo synthesized ORDER
We are always looking for ways to improve. Please tell us what you think.